Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 May 2006

Ann Rheum Dis. Published Online First: 25 October 2005. doi:10.1136/ard.2005.038828
Copyright © 2005 BMJ Publishing Group Ltd & European League Against Rheumatism.

Extended Report

Antibodies against human 60-kDa Heat-Shock Protein can not be associated with cardiovascular disease in patients with rheumatoid arthritis

Vokko P. van Halm 1, Marjan C. Slot 2, Michael T. Nurmohamed 3, Jan W. Cohen Tervaert 4, Ben A. Dijkmans 1 and Alexandre E. Voskuyl 1*

1 Department of Rheumatology, VU University Medical Center, Netherlands
2 Department of Clinical and Experimental Immunology, University Hospital Maastricht, Netherlands
3 Jan van Breemen Institute, Netherlands
4 Department of Clinical and Experimental Immunology, University Hospital Maastricht, Netherlands

* To whom correspondence should be addressed. E-mail: ae.voskuyl{at}vumc.nl.

Accepted 2 October 2005


Abstract

Objectives: Rheumatoid arthritis (RA) is associated with an unexplained increased risk of cardiovascular disease (CVD). Antibodies against human 60 kDa Heat-Shock Protein (anti-HSP60) are associated with the presence and severity of CVD. Therefore, we investigated whether anti-HSP60 antibodies are associated with prevalent CVD in patients with RA.

Methods: In a nested case control design anti-HSP60 antibody levels were measured in the serum samples of 192 RA patients. In a regression analysis we examined the association between prevalent CVD and anti-HSP60 antibodies and in addition the possible influence on this association of several demographic, RA and CVD related variables.

Results: In a random sample of 326 RA patients, we identified 48 cases who also suffered from CVD. Per case we found 3 controls having RA but without CVD (n=144), matched for sex, age, disease duration and smoking habits. A regression analysis showed no significant association between prevalent CVD and anti-HSP60 antibodies, odds ratio 1.00 (95%-CI: 0.997 - 1.004). After correcting for possible confounders, still no association was found.

Conclusions: In contrast to the general population, anti-HSP60 antibody titres are not associated with prevalent CVD in patients with RA. We postulate that these findings are the result of an altered immune response in RA to HSP60.

Keywords: Heat-Shock Protein 60 antibodies, cardiovascular disease, rheumatoid arthritis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs